Home / Sodium Bicarbonate / United States
US ATC B05CB04 · updated 2 Nov 2026
Sodium Bicarbonate shortage in United States
Is there a Sodium Bicarbonate shortage in United States?
Yes. As of 2 Nov 2026, 12 Sodium Bicarbonate products are reported short in United States, the first since 1 Mar 2017. No return date has been given. Main reason: not stated.
Also short in France. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01) limited | Hospira, Inc., a Pfizer Company | 1 Mar 2017 | not given | Other |
| US | Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02) limited | Hospira, Inc., a Pfizer Company | 1 Mar 2017 | not given | Increased demand Demand increase for the drug |
| US | Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14) | Hospira, Inc., a Pfizer Company | 1 Mar 2017 | not given | Not stated |
| US | Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35) | Hospira, Inc., a Pfizer Company | 1 Mar 2017 | not given | Other |
| US | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1) limited | Amphastar Pharmaceuticals, Inc. | 1 Mar 2017 | not given | Increased demand Demand increase for the drug |
| US | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3) | Long Grove Pharmaceuticals LLC | 1 Mar 2017 | not given | Not stated |
| US | Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4) | Exela Pharma Sciences, LLC | 24 Jul 2017 | not given | Not stated |
| US | Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05) | Fresenius Kabi USA, LLC | 24 Jul 2017 | not given | Not stated |
| US | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5) | Exela Pharma Sciences, LLC | 24 Jul 2017 | not given | Not stated |
| US | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4) | Exela Pharma Sciences, LLC | 24 Jul 2017 | not given | Not stated |
| US | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50) | Fresenius Kabi USA, LLC | 24 Jul 2017 | not given | Not stated |
| US | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-6637-14) discontinuation | Hospira, Inc., a Pfizer Company | 7 Nov 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).